Weil Company, Inc. Singular Genomics Systems, Inc. Put Options Transaction History
Weil Company, Inc.
- $239 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OMIC
# of Institutions
45Shares Held
24.7MCall Options Held
13.2KPut Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY4.98MShares$39.6 Million0.05% of portfolio
-
Arch Venture Management, LLC Chicago, IL3.8MShares$30.2 Million2.82% of portfolio
-
Qvidtvm Management LLC New York, NY2.51MShares$19.9 Million1.08% of portfolio
-
Ubs Group Ag2.21MShares$17.5 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.13MShares$16.9 Million0.02% of portfolio
About Singular Genomics Systems, Inc.
- Ticker OMIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 71,193,296
- Market Cap $565M
- Description
- Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...